CIRAX
Price
$83.83
Change
-$0.08 (-0.10%)
Updated
Aug 3 closing price
Net Assets
127.87B
FBBAX
Price
$26.27
Change
+$0.08 (+0.31%)
Updated
Aug 3 closing price
Net Assets
64.64M
Interact to see
Advertisement

CIRAX vs FBBAX

CIRAX vs FBBAX Comparison Chart in %
View a ticker or compare two or three
VS
CIRAX vs. FBBAX commentary
Aug 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIRAX is a Hold and FBBAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIRAX has more cash in the bank: 128B vs. FBBAX (64.6M). FBBAX pays higher dividends than CIRAX: FBBAX (3.79) vs CIRAX (2.67). CIRAX was incepted earlier than FBBAX: CIRAX (24 years) vs FBBAX (33 years). FBBAX (1.32) is less costly to investors than CIRAX (0.60). CIRAX is a more actively managed with annual turnover of: 50.00 vs. FBBAX (22.00). FBBAX initial investment is less costly to investors than CIRAX (4%) vs CIRAX (4%). CIRAX has a lower initial minimum investment than FBBAX: CIRAX (250) vs FBBAX (1000). CIRAX annual gain was more profitable for investors over the last year : 13.39 vs. FBBAX (-1.64). CIRAX return over 5 years is better than : 43.59 vs. FBBAX (3.63).
CIRAXFBBAXCIRAX / FBBAX
Total Expense Ratio0.601.3245%
Annual Report Gross Expense Ratio0.601.3245%
Fund Existence24 years33 years-
Gain YTD10.356-0.494-2,097%
Front Load4%6%61%
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets128B64.6M198,142%
Annual Yield % from dividends2.673.7970%
Returns for 1 year13.39-1.64-815%
Returns for 3 years43.123.711,164%
Returns for 5 years43.593.631,201%
Returns for 10 years95.9653.77178%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGBCX42.760.19
+0.45%
American Funds Global Balanced R-3
REMYX24.99N/A
N/A
Russell Inv Emerging Markets Y
EQIAX17.63N/A
N/A
Allspring Emerging Markets Eq Advtg A
GAGPX13.31N/A
N/A
Goldman Sachs Em Mkts Eq Insghts P
SBHCX14.67N/A
N/A
Segall Bryant & Hamill Small Cap Cre Ret